Odyssean LLC’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-122,087
Closed -$4.08M – 536
2026
Q2
$4.08M Buy
122,087
+54,675
+81% +$1.36M 0.66% 1
2026
Q1
$1.41M Buy
67,412
+45,182
+203% +$1.02M 0.52% 43
2025
Q4
$511K Buy
+22,230
New +$731K 0.37% 157

Other funds holding RARE

Odyssean LLC's RARE Position: Q3 2026 in Review

Odyssean LLC sold out of Ultragenyx Pharmaceutical (RARE) in Q3 2026, closing a stake of 122,087 shares — an estimated $4.08M sold.

Odyssean LLC first reported a position in RARE in Q4 2025 and held it in 3 quarters. The position peaked at $4.08M in Q2 2026. 268 funds tracked by Wall St. Rank hold RARE as of Q3 2026.

  • Odyssean LLC reported no remaining Ultragenyx Pharmaceutical position as of Q3 2026 after selling out during the quarter.
  • Odyssean LLC sold 122,087 Ultragenyx Pharmaceutical shares in Q3 2026, an estimated $4.08M.
  • Odyssean LLC first reported a position in Ultragenyx Pharmaceutical in Q4 2025 and held it in 3 quarters.
  • Odyssean LLC's Ultragenyx Pharmaceutical position peaked at $4.08M in Q2 2026.
  • 268 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2026.

Based on Odyssean LLC's 13F filing for Q3 2026, filed 16 Nov 2026.